KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biogen (BIIB) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to 0.03%.

  • Biogen's Return on Capital Employed fell 100.0% to 0.03% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.03%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.03% for FY2025, which is 100.0% down from last year.
  • Per Biogen's latest filing, its Return on Capital Employed stood at 0.03% for Q4 2025, which was down 100.0% from 0.02% recorded in Q3 2025.
  • Biogen's Return on Capital Employed's 5-year high stood at 0.18% during Q1 2021, with a 5-year trough of 0.05% in Q4 2023.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.01% (2023), whereas its average is 0.04%.
  • In the last 5 years, Biogen's Return on Capital Employed crashed by -2200bps in 2021 and then skyrocketed by 400bps in 2022.
  • Over the past 5 years, Biogen's Return on Capital Employed (Quarter) stood at 0.15% in 2021, then dropped by -25bps to 0.11% in 2022, then crashed by -147bps to 0.05% in 2023, then skyrocketed by 65bps to 0.02% in 2024, then plummeted by -83bps to 0.03% in 2025.
  • Its last three reported values are 0.03% in Q4 2025, 0.02% for Q3 2025, and 0.03% during Q2 2025.